Amniotic fluid stem cell administration can prevent epithelial injury from necrotizing enterocolitis
Authors:
- 24 September 2021
- journal article
- research article
- Published by Springer Nature in Pediatric Research
- Vol. 91 (1) , 101-106
Abstract
Background Stem cell therapy has been proven to rescue intestinal injury and stimulate intestinal regeneration in necrotizing enterocolitis (NEC). Specifically, stem cells derived from amniotic fluid (AFSCs) and mesenchymal stem cells (MSCs) derived from bone marrow have shown promising results in the treatment of experimental NEC. This study aims to examine the effects of AFSCs and MSCs on the prevention of intestinal injury during experimental NEC. Methods Supernatants from AFSC and MSC cultures were collected to perform proteomic analysis. Prior to NEC induction, mice received intraperitoneal injections of phosphate-buffered saline (PBS), 2 × 106 AFSCs, or 2 × 106 MSCs. Results We found that AFSCs grew faster than MSCs. Proteomic analysis indicated that AFSCs are primarily involved in cell development and growth, while MSCs are involved in immune regulation. Administering AFSCs before NEC induction decreased NEC severity and mucosal inflammation. Intestinal proliferation and endogenous stem cell activation were increased after AFSC administration. However, administering MSCs before NEC induction had no beneficial effects. Conclusions This study demonstrated that AFSCs and MSCs have different protein release profiles. AFSCs can potentially be used as a preventative strategy for neonates at risk of NEC, while MSCs cannot be used. Impact AFSCs and MSCs have distinct protein secretory profiles, and AFSCs are primarily involved in cell development and growth, while MSCs are involved in immune regulation. AFSCs are unique in transiently enhancing healthy intestinal epithelial cell growth, which offers protection against the development of experimental NEC. The prevention of NEC via the administration of AFSCs should be evaluated in infants at great risk of developing NEC or in infants with early signs of NEC.Keywords
This publication has 41 references indexed in Scilit:
- Amniotic fluid stem cells improve survival and enhance repair of damaged intestine in necrotising enterocolitis via a COX-2 dependent mechanismGut, 2013
- Bioprinted Amniotic Fluid-Derived Stem Cells Accelerate Healing of Large Skin WoundsStem Cells Translational Medicine, 2012
- Branched Chain Fatty Acids Reduce the Incidence of Necrotizing Enterocolitis and Alter Gastrointestinal Microbial Ecology in a Neonatal Rat ModelPLOS ONE, 2011
- Necrotizing EnterocolitisNew England Journal of Medicine, 2011
- Amniotic-Fluid Stem Cells: Growth Dynamics and Differentiation Potential after a CD-117-Based Selection ProcedureStem Cells International, 2011
- Insulin-Like Growth Factor-Binding Protein 7 Regulates Keratinocyte Proliferation, Differentiation and ApoptosisJournal of Investigative Dermatology, 2010
- Unraveling Insulin-Like Growth Factor Binding Protein-3 Actions in Human DiseaseEndocrine Reviews, 2009
- IGF binding protein-3 regulates hematopoietic stem cell and endothelial precursor cell function during vascular developmentProceedings of the National Academy of Sciences, 2007
- Isolation of amniotic stem cell lines with potential for therapyNature Biotechnology, 2007
- Epidermal Growth Factor Receptor Regulates Aberrant Expression of Insulin-Like Growth Factor-Binding Protein 3Cancer Research, 2004